Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Lactose (India) Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹109.55 |
|---|---|
| Day's Range | ₹106.20 - ₹115.50 |
| Open | ₹115.45 |
| 52 Week Range | ₹76.01 - ₹136.45 |
| Volume | 3,675 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 4.01 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 19.91 |
| TTM EPS (₹) | 5.50 |
| P/E Ratio | 21.63 |
| Book Value(₹) | 2.05 |
| PAT Margin (%) | 4.44 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 13.01 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 395.76 | 1163.99 |
| Expenses | N/A | N/A |
| PBT | 22.88 | 69.18 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 14.99 | 51.63 |
About Lactose (India) Ltd.
| Founded | 1991 |
|---|---|
| Managing Director | Atul Maheshwari |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,26,661.74 | 1,778.25 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,57,902.73 | 9,715.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,76,306.21 | 4,635.15 | 3,532.60 - 3,532.60 |
| Laurus Labs Ltd. | 1,29,242.68 | 2,392.00 | 917.95 - 917.95 |
| Zydus Lifesciences Ltd. | 1,24,089.48 | 1,244.00 | 835.50 - 835.50 |
| Apollo Hospitals Enterprise Ltd. | 1,20,779.11 | 8,400.00 | 6,696.50 - 6,696.50 |
| Lenskart Solutions Ltd. | 1,17,959.74 | 678.20 | 0.00 - 0.00 |
| Dr. Reddy's Laboratories Ltd. | 1,12,698.53 | 1,350.20 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,11,488.55 | 1,380.00 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,02,796.60 | 2,488.75 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Nov
1
2026
Posted on Nov 1st 2026
Sigachi Industries - Quaterly Results
The sales figure stood at Rs. 1134.85 millions for the September 2026 quarter. The mentioned figure indicates a growth of about 35.19% as compared to Rs. 839.43 millions during the year-ago period.A slender decline of -23.68% was recorded to Rs. 89.77 millions from Rs. 117.62 millions in the corresponding previous quarter.Operating profit surged to 172.97 millions from the corresponding previous quarter of 91.58 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 1134.85 | 839.43 | 35.19 | 2117.61 | 1949.20 | 8.64 | 3790.42 | 4078.33 | -7.06 |
| Other Income | 2.19 | 24.92 | -91.21 | 6.62 | 64.33 | -89.71 | 82.28 | 200.77 | -59.02 |
| PBIDT | 172.97 | 91.58 | 88.87 | 308.98 | 370.60 | -16.63 | 582.27 | 943.38 | -38.28 |
| Interest | 31.63 | 25.27 | 25.17 | 53.49 | 46.74 | 14.44 | 101.34 | 106.57 | -4.91 |
| PBDT | 141.34 | 112.87 | 25.22 | 255.49 | -839.64 | -130.43 | -701.20 | 836.81 | -183.79 |
| Depreciation | 36.21 | 33.13 | 9.30 | 72.42 | 72.63 | -0.29 | 144.31 | 129.22 | 11.68 |
| PBT | 105.13 | 79.74 | 31.84 | 183.07 | -912.27 | -120.07 | -845.51 | 707.59 | -219.49 |
| TAX | 15.36 | -37.88 | -140.55 | 28.22 | -38.45 | -173.39 | -50.05 | 230.92 | -121.67 |
| Deferred Tax | -8.40 | -37.88 | -77.82 | -16.80 | -38.45 | -56.31 | -54.30 | 105.18 | -151.63 |
| PAT | 89.77 | 117.62 | -23.68 | 154.85 | -873.82 | -117.72 | -795.46 | 476.67 | -266.88 |
| Equity | 382.12 | 382.12 | 0.00 | 382.12 | 382.12 | 0.00 | 382.12 | 382.12 | 0.00 |
| PBIDTM(%) | 15.24 | 10.91 | 39.71 | 14.59 | 19.01 | -23.26 | 15.36 | 23.13 | -33.59 |
Read More
Nov
1
2026
Posted on Nov 1st 2026
Unick Fix-A-Form - Quaterly Results
Net sales declined -11.11% to Rs. 131.42 million from Rs. 147.84 millions.The Company's Net profit for the September 2026 quarter have declined marginally to Rs. 4.17 millions as against Rs. 5.04 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 19.33 millions from 18.21 millions in the quarter ended September 2026.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 131.42 | 147.84 | -11.11 | 318.20 | 319.34 | -0.36 | 589.07 | 559.79 | 5.23 |
| Other Income | 0.97 | 0.56 | 73.21 | 0.98 | 0.78 | 25.64 | 3.88 | 1.76 | 120.45 |
| PBIDT | 19.33 | 18.21 | 6.15 | 49.19 | 49.70 | -1.03 | 71.19 | 91.40 | -22.11 |
| Interest | 4.37 | 5.27 | -17.08 | 9.78 | 12.89 | -24.13 | 23.68 | 20.66 | 14.62 |
| PBDT | 14.96 | 12.94 | 15.61 | 39.41 | 36.81 | 7.06 | 47.51 | 70.74 | -32.84 |
| Depreciation | 9.67 | 9.02 | 7.21 | 19.25 | 17.84 | 7.90 | 36.20 | 35.60 | 1.69 |
| PBT | 5.29 | 3.92 | 34.95 | 20.16 | 18.97 | 6.27 | 11.31 | 35.14 | -67.81 |
| TAX | 1.12 | -1.12 | -200.00 | 4.92 | 2.70 | 82.22 | 2.79 | 9.04 | -69.14 |
| Deferred Tax | -0.18 | -2.12 | -91.51 | -0.10 | -2.05 | -95.12 | 0.39 | -4.55 | -108.57 |
| PAT | 4.17 | 5.04 | -17.26 | 15.24 | 16.27 | -6.33 | 8.52 | 26.10 | -67.36 |
| Equity | 54.85 | 54.85 | 0.00 | 54.85 | 54.85 | 0.00 | 54.85 | 54.85 | 0.00 |
| PBIDTM(%) | 14.71 | 12.32 | 19.41 | 15.46 | 15.56 | -0.67 | 12.09 | 16.33 | -25.98 |
Read More
Nov
1
2026
Posted on Nov 1st 2026
RainbowChildrenS Med - Quaterly Results
A fair growth of 19.22% in the revenue at Rs. 4869.91 millions was reported in the September 2026 quarter as compared to Rs. 4084.96 millions during year-ago period.A meek growth of 2.63% was reported for the quarter ended September 2026 to Rs. 750.93 millions from Rs. 731.67 millions.Operating Profit saw a handsome growth to 1595.88 millions from 1488.91 millions in the quarter ended September 2026.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 4869.91 | 4084.96 | 19.22 | 8975.38 | 7432.44 | 20.76 | 15456.60 | 14545.06 | 6.27 |
| Other Income | 80.92 | 81.73 | -0.99 | 208.49 | 274.58 | -24.07 | 434.54 | 489.49 | -11.23 |
| PBIDT | 1595.88 | 1488.91 | 7.18 | 2870.04 | 2676.97 | 7.21 | 5433.11 | 5234.23 | 3.80 |
| Interest | 199.14 | 173.09 | 15.05 | 391.63 | 347.02 | 12.86 | 713.96 | 695.94 | 2.59 |
| PBDT | 1396.74 | 1315.82 | 6.15 | 2478.41 | 2329.95 | 6.37 | 4703.76 | 4538.29 | 3.65 |
| Depreciation | 398.09 | 331.82 | 19.97 | 774.35 | 657.75 | 17.73 | 1362.61 | 1317.48 | 3.43 |
| PBT | 998.65 | 984.00 | 1.49 | 1704.06 | 1672.20 | 1.91 | 3341.15 | 3220.81 | 3.74 |
| TAX | 247.72 | 252.33 | -1.83 | 426.07 | 423.33 | 0.65 | 840.99 | 844.98 | -0.47 |
| Deferred Tax | -57.47 | -27.87 | 106.21 | -68.71 | -22.06 | 211.47 | -73.38 | -31.54 | 132.66 |
| PAT | 750.93 | 731.67 | 2.63 | 1277.99 | 1248.87 | 2.33 | 2500.16 | 2375.83 | 5.23 |
| Equity | 1015.66 | 1015.59 | 0.01 | 1015.66 | 1015.59 | 0.01 | 1015.59 | 1015.52 | 0.01 |
| PBIDTM(%) | 32.77 | 36.45 | -10.09 | 31.98 | 36.02 | -11.22 | 35.15 | 35.99 | -2.32 |
Read More
Nov
1
2026
Posted on Nov 1st 2026
Advanced Enzyme Tech - Quaterly Results
The revenue zoomed 18.51% to Rs. 1371.68 millions for the quarter ended September 2026 as compared to Rs. 1157.48 millions during the corresponding quarter last year.Handsome Net Profit growth of 87.17% reported above the corresponding previous quarter figure of Rs. 417.05 millions to Rs. 222.82 millions.Operating profit for the quarter ended September 2026 rose to 543.16 millions as compared to 326.70 millions of corresponding quarter ended September 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 1371.68 | 1157.48 | 18.51 | 2530.25 | 2407.72 | 5.09 | 4527.66 | 3514.11 | 28.84 |
| Other Income | 163.97 | 30.79 | 432.54 | 186.84 | 569.31 | -67.18 | 633.88 | 614.90 | 3.09 |
| PBIDT | 543.16 | 326.70 | 66.26 | 870.15 | 1170.48 | -25.66 | 1738.22 | 1321.69 | 31.51 |
| Interest | 0.31 | 0.49 | -36.73 | 0.68 | 1.02 | -33.33 | 2.07 | 2.36 | -12.29 |
| PBDT | 542.85 | 326.21 | 66.41 | 869.47 | 1169.46 | -25.65 | 1697.57 | 1319.33 | 28.67 |
| Depreciation | 31.73 | 30.02 | 5.70 | 60.94 | 59.31 | 2.75 | 120.83 | 114.05 | 5.94 |
| PBT | 511.12 | 296.19 | 72.56 | 808.53 | 1110.15 | -27.17 | 1576.74 | 1205.28 | 30.82 |
| TAX | 94.07 | 73.37 | 28.21 | 168.02 | 147.52 | 13.90 | 258.68 | 181.08 | 42.85 |
| Deferred Tax | 1.25 | 0.54 | 131.48 | 8.56 | 0.28 | 2957.14 | -12.01 | 12.22 | -198.28 |
| PAT | 417.05 | 222.82 | 87.17 | 640.51 | 962.63 | -33.46 | 1318.06 | 1024.20 | 28.69 |
| Equity | 220.53 | 223.76 | -1.44 | 223.95 | 223.76 | 0.08 | 223.85 | 223.76 | 0.04 |
| PBIDTM(%) | 39.60 | 28.23 | 40.29 | 34.39 | 48.61 | -29.26 | 38.39 | 37.61 | 2.07 |
Read More
Nov
1
2026
Posted on Nov 1st 2026
Shree Ganesh Remed. - Quaterly Results
The sales slipped to Rs. 232.95 millions for the September 2026 quarter as against Rs. 303.15 millions during the year-ago period.The Company to register a -67.02% fall in the net profit for the quarter ended September 2026.The Operating Profit of the company witnessed a decrease to 53.42 millions from 103.09 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 232.95 | 303.15 | -23.16 | 376.55 | 549.83 | -31.52 | 1092.86 | 1085.96 | 0.64 |
| Other Income | 14.06 | 6.90 | 103.77 | 23.45 | 13.52 | 73.45 | 30.30 | 37.30 | -18.77 |
| PBIDT | 53.42 | 103.09 | -48.18 | 96.34 | 182.68 | -47.26 | 380.50 | 429.42 | -11.39 |
| Interest | 5.75 | 10.10 | -43.07 | 8.94 | 19.50 | -54.15 | 35.62 | 20.77 | 71.50 |
| PBDT | 47.67 | 92.99 | -48.74 | 87.40 | 163.18 | -46.44 | 344.88 | 408.65 | -15.61 |
| Depreciation | 25.03 | 25.87 | -3.25 | 49.44 | 50.07 | -1.26 | 104.73 | 95.67 | 9.47 |
| PBT | 22.64 | 67.12 | -66.27 | 37.96 | 113.11 | -66.44 | 240.15 | 312.98 | -23.27 |
| TAX | 6.29 | 17.55 | -64.16 | 10.40 | 29.04 | -64.19 | 62.42 | 81.99 | -23.87 |
| Deferred Tax | 0.58 | 2.17 | -73.27 | 1.23 | 3.47 | -64.55 | 5.33 | -0.45 | -1284.44 |
| PAT | 16.35 | 49.57 | -67.02 | 27.56 | 84.07 | -67.22 | 177.73 | 230.99 | -23.06 |
| Equity | 128.38 | 128.38 | 0.00 | 128.38 | 128.38 | 0.00 | 128.38 | 128.38 | 0.00 |
| PBIDTM(%) | 22.93 | 34.01 | -32.57 | 25.58 | 33.22 | -22.99 | 34.82 | 39.54 | -11.95 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Lactose (India) Ltd. is ₹109.55 as of 2026-10-30.
The market capitalisation of Lactose (India) Ltd. is ₹137.91 as of 2026-10-30.
The 1-year return of Lactose (India) Ltd. is -6.35% as of 2026-10-30.
The P/E ratio of Lactose (India) Ltd. is 21.63 as of 2026-11-01.
The 52-week high and low of Lactose (India) Ltd. are ₹136.45 and ₹76.01, respectively, as of 2026-10-30.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
